economic impact of biosimilars in oncology
Published 4 years ago • 208 plays • Length 6:01Download video MP4
Download video MP3
Similar videos
-
11:00
examining the economic impacts of biosimilars in oncology
-
5:35
biosimilars in oncology: long-term financial benefit
-
3:21
biosimilars in oncology: future directions
-
3:46
biosimilars: how much evidence do we need?
-
0:29
the immediate economic impact of biosimilars
-
57:58
lecture: the therapeutic pipeline for age-related macular degeneration and diabetic macular edema
-
5:09
the challenges in manufacturing biologics
-
6:54
the biosimilar boom and the coming humira price war
-
6:00
quick guide to biosimilars
-
1:07
impact of biosimilars on the field of oncology
-
16:47
what is needed and what is the role of biosimilars?
-
7:20
biosimilars in oncology: addressing awareness
-
1:48
dr. markman on the concept of biosimilars in oncology
-
6:43
biosimilars
-
51:06
biosimilars and oncology clinical pathways: perfect together
-
57:53
biosimilars: what you need to know
-
0:44
dr. hamilton on the impact of biosimilars in oncology
-
1:05
biosimilar trastuzumab: a cost effective alternative for breast cancer treatment
-
7:30
generics and biosimilars
-
32:37
biologics, biosimilars, and the two-fold u.s. approval framework’s possible impact on prices
-
1:38
dr. hurvitz on the impact of biosimilars